Navigation Links
What's in a Name? When It Comes to Drugs, Plenty
Date:8/6/2008

Doctors and pharmacists struggle to keep pace with medications that sound alike but aren't

WEDNESDAY, Aug. 6 (HealthDay News) -- You say tomato, I say tomahto.

Which is all well and good as long as we're talking about fruits and vegetables -- but not so good if the nurse says "fentanyl" and the hospital pharmacist hears "sufentanil," as happened to one patient preparing for an endoscopy.

The patient, given an opioid about 10 times more potent than the one prescribed, ended up in cardiopulmonary resuscitation.

The problem of sound-alike/look-alike drug names and its close cousin -- plain old mispronunciation -- abounds. The dilemma would almost be comical, except that people can die.

"[Mispronunciation] is more than a challenge, it's also a danger," said Robert Stanberry, assistant professor of pharmacy practice at Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy.

"If you pronounce it wrong, you may end up with the wrong drug," added Marilyn Storch, coordinator for all patient safety projects and the health care quality and information department at U.S. Pharmacopeia (USP), the official "standards-setting" authority for medications, dietary supplements and other health-care products sold in the United States.

And more words -- and syllables -- are entering the drug world all the time.

"As drugs proliferate, they start to sound alike, like Celexa and Celebrex," said Dr. Kennedy, director of geriatric psychiatry at Montefiore Medical Center in New York City. "It's just going to get worse with increases in the number of drugs and in the number of unfamiliar names."

Also, bear in mind that for countless physicians, many medications that they were trained to pronounce and prescribe when they were in medical school are no longer used, Kennedy added.

The Celexa/Celebrex combination is a classic example, but there are others. Losec, for heartburn, was confused so often with Lasix, a diuretic, that the name was changed to Prilosec. But now that gets confused with Prozac, according to a USP report.

And the Alzheimer's drug Reminyl was changed to Razadyne after mix-ups involving Amaryl, which lowers blood sugar. The mix-ups reportedly resulted in two deaths.

And what about names that are just too long? The generic name for Flurizan, an investigational Alzheimer's drug, is tarenflurbil. "It's almost too many syllables to pronounce," Kennedy said. Does anyone know how to pronounce bapineuzumab, another investigational drug for Alzheimer's?

The report issued earlier this year by USP on the relationship between drug names and medication errors reviewed more than 26,000 records. It found almost 1,500 different drugs implicated in medication errors as a result of names that looked or sounded alike. The drugs in question added up to 3,170 pairs, double the number of pairs found in a 2004 report. According to the document, 1.4 percent of the errors resulted in patient harm, including seven that may have played a part in patient death.

To be fair, there have been initiatives aiming to fix the problem, such as a pronunciation guide from the United States Adopted Names Council, and the "good naming practices" effort from the drug industry trade group PhRMA (Pharmaceutical Research and Manufacturers of America), not to mention the Unique Ingredient Identifier system being developed by USP and the U.S. Food and Drug Administration, as well as efforts to bar code all drugs.

Since 2002, the USP Nomenclature Expert Committee has been reviewing drug-name pronunciations to ensure consistency. The council actually changed the entry in the dictionary for ibuprofen to reflect a suggested pronunciation.

But what happens when globalism comes into play?

"As far as pronunciation of words, my experience is that it's pretty much all over the place," Stanberry said. Americans and the British pronounce "barbiturate" differently and both are right.

"Even if you were pronouncing something correctly, if you had a really deep Southern drawl, it's not going to sound the same. Or if you come in with an English accent or a French accent or a Texas accent, you may be pronouncing it correctly, but it's not going to sound the same," Storch said.

And sometimes, no one seems to know the correct pronunciation.

Stanberry recalls being at a conference last year and listening to a speaker repeatedly mispronounce a drug name -- or so he believed. "I thought, 'This guy's just mispronouncing this terribly, and he's the speaker.' But he actually studied under the guy who discovered the drug."

Then again, the speaker was British. Stanberry is American.

More information

The Merck Manuals has a guide to drug-name pronunciations.



SOURCES: Robert Stanberry, J.D., Pharm.D., assistant professor of pharmacy practice, Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy, Kingsville; Gary Kennedy, M.D., director, geriatric psychiatry, Montefiore Medical Center, New York City; Marilyn Storch, coordinator, patient safety projects and health care quality and information department, U.S. Pharmacopeia, Rockville, Md.; 2008, USP report


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Whats in a name? Initials linked to success, study shows
2. No substitute for hard work: Creatine supplementation does not improve exercise outcomes in COPD
3. CollaborateMD Becomes a Habitat for Humanity International HopeBuilder
4. Magellan Biosciences Companies to Feature Diagnostic Products Designed to Improve Health Outcomes at the Clinical Lab Expo
5. IPRO Welcomes Back Anthony Shih as Chief Quality Officer, Strategic Planning Lead
6. Trusted LASIK Surgeons Welcomes Top LASIK Expert Randy Epstein, M.D. of Chicago to it's Unique Lasik Directory Service
7. With $2M NIH grant, FSU becomes 1 of worlds top imaging centers
8. New research from Rhode Island Hospital may help predict outcomes for stomach cancer patients
9. Brain Cancer Vaccines Immune Response Key to Outcomes
10. Brain cancer study: Magnitude of post-vaccine immune response linked to clinical outcomes
11. When it comes to putting, Tiger and Nicklaus might not have best advice
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... , ... December 04, 2016 , ... ... major cosmetic surgery can now take advantage of a cosmetic procedure known as ... rejuvenation treatment that reduces the appearance of age spots, fine lines, uneven ...
(Date:12/4/2016)... ... December 04, 2016 , ... Responsible dental care hinges ... brush properly to achieve optimal results. This important necessity inspired an inventor from Las ... a way to ensure that people break or avoid bad techniques of brushing the ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... December 02, 2016 , ... On Dec. 2, 2016, CURE® magazine will host ... honoring the 2016 MPN Heroes—eight individuals who have made a difference in the field ... the standard of care, demonstrating leadership within the MPN community and/or a commitment to ...
(Date:12/2/2016)... Dothan, AL (PRWEB) , ... December 02, 2016 ... ... leaders from across the Dothan-Wiregrass Area in Alabama are expected to attend the ... Mike Schmitz, will help provide scholarship funds for area students and operating support ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... , Dec. 5, 2016 ... hydroxyurea (HU) in Complete Hematologic Response (CHR) ... ropeginterferon alfa-2b versus HU AOP will submit ... CONTINUATION-PV to obtain European marketing authorization in the coming months ... the FDA as it seeks approval for commercialization in the ...
(Date:12/4/2016)... 2016 Sickle cell disease (SCD) is an ... cells that get stuck in veins and block blood ... and complications leading to death. Each year, approximately 300,000 ... most of them lack access to comprehensive care or ... therapy for SCD, a pill called hydroxyurea approved more ...
(Date:12/2/2016)... SILVER SPRING, Md. , Dec. 2, 2016 /PRNewswire-USNewswire/ ... a new indication for Jardiance (empagliflozin) to reduce the ... 2 diabetes mellitus and cardiovascular disease. ... adults with type 2 diabetes mellitus," said Jean-Marc ... Metabolism and Endocrinology Products in FDA,s Center for Drug ...
Breaking Medicine Technology: